Europe - Pharmaceutical Executive

ADVERTISEMENT

Europe

Europe Gears Up to Attack Counterfeit Medicines—But Only Some of Them

July 1, 2014

Cross-sector partnership seeks support for a pan-European system to keep fake drugs out, but obstacles are many.

Hopes High as EU Heads Into Leadership Change

June 1, 2014

Rare allies—innovator and generic pharmas—are calling for policy integration in Europe. But ideology and newfound scepticism on the merits of drugs in healthcare could complicate the effort.

Pharma MBAs — From Mini Courses to the Full Monty

May 23, 2014

John Ansell assesses the wide range of pharma MBA courses currently available, from the five-day "mini MBA" to year-long programs of study.

Rebuilding European Pharma's Competitive Agenda

May 19, 2014

Because of the tougher conditions they face and shifts in ownership and corporate strategy, EFPIA and EGA have started to work together much more closely.

Whatever Happened To Faster Reimbursement For Generics In Europe?

April 1, 2014

The plan to accelerate generic pricing and reimbursement has become another tragic European casualty.

UDG Healthcare Integrates Sales, Marketing and Medical Services Offerings

February 4, 2014

UDG Healthcare Integrates Sales, Marketing and Medical Services Offerings

Will Europe's Regulatory Watchdog Come Of Age In 2014?

February 1, 2014

Reflector looks at the growing pains of the European Medicine Agency (EMA) as it faces key policy challenges of 2014.

Russia's Bet on Biopharma

January 21, 2014

Can innovation trump ideology? Russia faces a stark choice in betting on the visible hand of government in promoting a "world class" biopharmaceutical sector, writes William Looney.

Pay for Delay?

October 1, 2013

Europe follows the United States with a harsh new spotlight on agreements that slow generic entry for medicines losing exclusivity.

ADVERTISEMENT

Click here